These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 39335624)

  • 1. Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.
    Acharya SK; Shai S; Choon YF; Gunardi I; Hartanto FK; Kadir K; Roychoudhury A; Amtha R; Vincent-Chong VK
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways.
    Joshi J; Patel H; Bhavnagari H; Tarapara B; Pandit A; Shah F
    Crit Rev Oncog; 2022; 27(4):65-82. PubMed ID: 37199303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
    Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
    Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.
    Borlongan MC; Wang H
    Front Cell Dev Biol; 2023; 11():1125174. PubMed ID: 37305676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
    Shahoumi LA
    Front Oral Health; 2021; 2():685236. PubMed ID: 35048028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
    Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
    Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orai3 Calcium Channel Contributes to Oral/Oropharyngeal Cancer Stemness through the Elevation of ID1 Expression.
    Nguyen A; Sung Y; Lee SH; Martin CE; Srikanth S; Chen W; Kang MK; Kim RH; Park NH; Gwack Y; Kim Y; Shin KH
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
    Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
    J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation.
    Hu FW; Yu CC; Hsieh PL; Liao YW; Lu MY; Chu PM
    Oncotarget; 2017 Nov; 8(55):93912-93923. PubMed ID: 29212198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of hydrogels for targeting cancer stem cells in cancer treatment.
    Li F; Li Z; Wei C; Xu L; Liang Y; Yan J; Li Y; He B; Sun C
    Biomed Pharmacother; 2024 Nov; 180():117486. PubMed ID: 39321506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.
    Kaur G; Sharma P; Dogra N; Singh S
    Curr Treat Options Oncol; 2018 Mar; 19(4):20. PubMed ID: 29556842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell division patterns and chromosomal segregation defects in oral cancer stem cells.
    Kaseb HO; Lewis DW; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.